News
Five female founded mental health start-ups to watch
We list some of the best female-founded mental health apps
As the femtech world and wellness industry start to combine. We explore the mental health apps, startups and female-founded businesses you need to know.
Mental health conditions, especially after two years of pandemic restrictions and lockdowns, are on the rise. It is estimated that 1 in 4 people in England will experience some form of mental health issue such as depression or anxiety each year.
Spiritune
Spiritune combines principles of neuroscience and music therapy to inspire positive mental health outcomes. It aims to help reduce stress while increasing emotional regulation, productivity and performance through the music-based app.
The app was created by Jamie Pabst after she struggled with her own stress levels while working in the finance industry in New York. She realised the lack of accessible resources and wanted to create something impactful. The company highlights that headphones can become health tools allowing people to support their emotional health and perform better.
Jamie wrote: “Music is one of the most powerful stimuli that addresses the brain networks that underlie stress, emotions, motivation and reward. My vision to combine the effectiveness of music therapy and the accessibility of audio to help people better manage stress drove the creation of Spiritune.
Appreciating the role our auditory system plays in our health through my mom’s hearing loss, and understanding the significance of music in neurological function through my sister’s pursuits in music therapy, I am dedicated to bringing the vast benefits of music to people and organizations globally to create better health outcomes.”
It also offers a workplace setting that can help employers to boost productivity and employee well-being.
Thymia
Thymia is a health tech company with a difference founded by CEO Emilia Molimpakis.
Thymia researchers developed a game based on neuropsychology combined with facial micro-expression analysis and speech pattern analysis to make faster mental health assessments. Its’s system allows clinicians a fun and engaging way to monitor their patient’s health. The game records subtle differences that doctors may miss and it also offers a way to monitor patients from home.
The app may have increased benefits for women in that it is also being developed to search for early signs of Alzheimer’s and Parkinsons’ Disease. Although both diseases affect both sexes, studies show Alzheimer’s is more prevalent in women. This is reversed when it comes to Parkinson’s Disease as men are 1.5 times more likely to develop the condition. However, women have a higher mortality rate and faster progression of the disease.
Speaking with Health Tech World, Emilia said: “In the patient’s view, they are just interacting with beautifully animated screens. However, what we are doing on the backside is where we are looking for specific patterns of behaviour because depression is associated with differences in cognitive function, psychological and behavioural patterns. Put all of those together and you get a signature for depression, Alzheimer’s or Parkinson’s.”
Thymia secured €920k at the end of June 2021 from investors to help grow the company.
Moody Month
While practising good mental can be essential for every day of the month, there are times when it may be a little more difficult than others.
Pre-menstrual stress (PMS) can cause mood swings, tension, anxiety or depression. It can also cause social withdrawal and irritability. Although people with periods will recognise the start of their period, it can be tricky to know what is PMS or what may be depression or anxiety.
Moody Month, founded by Amy Thomson, helps users to receive a forecast of information on what is happening in their bodies each day. Amy was inspired to create the app after her periods stopped due to stress, travel and burn-out while working in event management in London. She began searching for answers but was shocked to find a severe lack of information available for women. She also felt that period tracking apps stopped short at providing long term care for the entire cycle.
The app can help users to optimise their well-being by changing their mood, food and following fitness advice. It also tracks your hormonal cycle to better understand your moods and symptoms making it easier to recognise when it may be PMS. The more information input to Moody Month, the better the app is able to track and deliver information.
The best part?
The app is free unless you purchase something when using it.
Heart it out
Femtech products or solutions are often designed after founders become frustrated by a gap not addressed in women’s healthcare. When it comes to mental health start-up, Heart It Out, that’s exactly what happened.
Nithya J Rao became concerned by the lack of psychologists practising in India which led to the creation of the platform. The result was a data-driven platform that can help to train psychologists for 16 weeks before they meet a patient. It also offers therapy to address issues such as depression and anxiety.
The startup also launched a free helpline called Briefly during lockdown which aimed to provide access to a network of 27 volunteers psychologists. They went on to help more than 600 patients with trauma and anxiety.
Patients can self-refer themselves through the platform for a number of different therapies including couple, family and child services. It also offers a ‘supervision’ service where professionals can join two or more psychology professionals in a continuous, collaborative, and supportive process. It aims to facilitate the exploration, monitoring and enhancement of professional functioning.
The website states: “Heart It Out began humbly as a ‘Room on the Roof’ in a quaint neighbourhood, providing a safe space for people to talk their hearts out. Today, it is a tech platform poised to provide confidential and non-judgemental access to mental healthcare, to 1.5 billion people by 2030.”
Altopax
Altopax combines care with community by offering a virtual group therapy platform aimed at connecting mental healthcare providers with patients who need care.
Pharmaceutical and health investor Narmeen Azad created the platform to help others connect with a group of peers who are also experiencing the same mental health condition or chronic illness. Healthcare providers can also connect with other professionals to discuss personalised, integrated care.
You have until Friday to nominate your femtech company of the year.
The award is one of 10 featuring at Femtech World’s third annual awards event, which attracts entries from across the UK, EU and Europe.
The Company of the Year Award is for companies that have demonstrated exceptional leadership in tackling women’s health needs through groundbreaking products, services or platforms that are shaping the future of global femtech.
If your company is driving innovation, impact and growth in this space, this award was made for you.
About the sponsor: Femovate
The category is backed by Femovate, the global femtech incubator using design to fuel innovation across every stage of a woman’s health journey, from proactive prevention through to personalised treatment.
Femovate has invested over US$2 million in design capital, working side-by-side with founding teams to bring market-ready solutions to life.
The startups it supports have collectively raised US$120 million, launched 30 products, and secured seven FDA clearances.
Why enter?
The Femtech World Awards are free to enter.
Winners and shortlisted companies receive extensive coverage across all Femtech World platforms.
Winners will also receive a trophy and the opportunity to be featured in an interview for the publication.
Find out more about the Femtech World Award and enter here by 4pm BST on Friday 17.
Women with osteoporosis may be more likely to carry a gene linked to Alzheimer’s, according to new research.
Scientists found that APOE4, the most common genetic risk factor for Alzheimer’s, can weaken bone quality in women, even when standard scans appear normal.
The study, carried out by researchers at the Buck Institute for Research on Ageing in California, US, and UC San Francisco, suggests the gene may damage bone at a microscopic level long before any visible signs.
These changes can emerge as early as midlife and remain invisible to routine imaging tests used to assess bone strength.
The findings suggest a link between Alzheimer’s risk and skeletal health and could help pave the way for earlier detection of both conditions.
Professor Birgit Schilling, a senior author of the study, said: “What makes this finding so striking is that bone quality is being compromised at a molecular level that a standard bone scan simply will not catch.
“APOE4 is quietly disrupting the very cells responsible for keeping bone strong – and it is doing this specifically in females, which mirrors what we see with Alzheimer’s disease risk.”
Doctors have long observed that people with Alzheimer’s suffer higher rates of bone fractures, while osteoporosis in women is known to be one of the earliest predictors of the disease.
Now scientists believe they may have uncovered why.
Researchers led by Dr Charles Schurman carried out a detailed analysis of proteins in aged mouse bone and found that tissue was unusually rich in molecules linked to neurological disease, including those associated with Alzheimer’s.
In particular, long-lived bone cells known as osteocytes showed elevated levels of APOE, with levels twice as high in older female mice compared with younger or male animals.
Further experiments using genetically modified mice revealed that APOE4 had a strong and sex-specific impact on both bone and brain tissue.
The disruption at the protein level was even greater in bone than in the brain.
However, the bone structure itself appeared completely normal under scans.
Instead, the gene interfered with a key maintenance process inside bone cells, preventing them from repairing microscopic channels that keep bones strong and resilient.
When this process breaks down, bones become more fragile even if they look healthy on standard imaging.
These results suggest bone cells could potentially act as early biological warning signs of cognitive decline in women carrying APOE4.
Professor Lisa Ellerby, another senior author, said: “We think targeting these cells may open a new front in preserving bone quality in this population.”
Experts say the findings highlight the need to view the body as an interconnected system rather than treating diseases in isolation.
Dementia, of which Alzheimer’s is the most common form, remains one of the UK’s biggest health challenges.
Around 900,000 people are currently living with the condition, a figure expected to rise to 1.6 million by 2040.
It is already the leading cause of death, responsible for more than 74,000 deaths each year.
Health secretary Wes Streeting has relaunched England’s women’s health strategy, vowing to stop women being “gaslit” by doctors.
Speaking before publication of the renewed strategy, the health secretary said the NHS was “failing women” and set out measures to help them access the healthcare they need.
The government said the strategy would include a new standard of care to ensure women were offered pain relief for invasive procedures, such as fitting a contraceptive coil and hysteroscopies.
Feedback would be directly linked to provider funding through a new trial, giving women more power to affect change if they have a poor experience.
Action would also be taken to ensure women no longer face long waits for diagnoses for conditions such as endometriosis, which can take a decade to diagnose.
Streeting said: “[Women] have for so long been let down by a healthcare system that too often gaslights women, treating their pain as an inconvenience and their symptoms as an overreaction.
“Whether it’s being passed from one appointment to another for conditions like endometriosis and fibroids, or a lack of proper pain relief during invasive procedures, through to having to navigate symptoms for years before receiving a diagnosis, it’s clear the system is failing women.
“Women’s voices must be central to delivering effective, respectful and empathetic care. We need to hit medical misogyny where it hurts – the wallet.
“Today’s renewed strategy will tackle the issues women face every day and ensure no woman is left fighting to be heard.”
A report last month by the women and equalities committee found that gynaecological and menstrual health had not been “sufficiently prioritised” by the government.
MPs said parts of the 10-year women’s health strategy, launched in 2022 by the Conservatives, were at risk of being scaled back or discontinued under wider changes to the NHS.
These included initiatives that had reduced waiting lists and improved women’s access to healthcare, such as women’s health hubs.
Sarah Owen, chair of the committee and a Labour MP, said: “This would be a disaster for girls’ and women’s menstrual healthcare, when it is in dire need of more support.
“It is a national scandal that nearly half a million women are on hospital gynaecology waiting lists when there are effective treatments that could be administered in primary and community care, if only they could access them.”
The report said women faced “medical misogyny” and were left to “suck it up” and suffer in pain for years because of a lack of awareness of women’s health conditions.
A redesign of clinical pathways for some women’s health issues will aim to speed up diagnosis and treatment, and there will be a review of support for families who experience repeated baby loss.
The government also promised a “single referral point” to ensure women were directed to the right place the first time they sought help.
Dr Sue Mann, NHS England’s women’s health director, said too many women were dismissed for “serious symptoms” that affected every part of their lives.
“The renewed women’s health strategy will build significantly on the work the NHS has been doing to ensure women are heard and get the specialist care they need,” she said.
Women’s health groups cautiously welcomed the renewed strategy. Emma Cox, chief executive of Endometriosis UK, said decisive action would be vital to improve women’s healthcare in England.
Entrepreneur2 weeks agoThree sessions that show exactly where women’s health is heading in 2026
News4 weeks agoLuna and Kindbody partner to bring data-driven insight to women’s health and fertility care
News4 weeks agoFemtech World Awards announces deadline extension
Fertility4 weeks agoMenstruation costs £20,359 a lifetime, sparking calls for Government action
Menopause3 weeks agoCalifornia plans US$3.4m menopause care overhaul
News4 weeks agoHalogen Ventures surpasses 100 investments in female-founded startups
Menopause3 weeks agoWatchdog bans five ads for women’s heath claims
Pregnancy2 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
1 Comment